Ascendis Pharma A/S (ASND) Revenue (2013 - 2026)
Ascendis Pharma A/S (ASND) revenue from Mar 31, 2013 to Mar 31, 2026. The TTM Ascendis Pharma A/S (ASND) revenue is $1.01B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Ascendis Pharma A/S (ASND) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +158.58% |
| 3 Years TTM | +131.03% |
| 5 Years TTM | +175.50% |
| 10 Years TTM | +62.07% |
| All Time TTM | +35.25% |
Annual Revenue change of Ascendis Pharma A/S (ASND)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $290M | -64.36% |
| 2025 | $812M | +115.81% |
| 2024 | $376M | +27.80% |
| 2023 | $295M | +439.74% |
| 2022 | $55M | +517.19% |
| 2021 | $8.84M | +4.17% |
| 2020 | $8.49M | -43.42% |
| 2019 | $15M | +23.67% |
| 2018 | $12M | +559.97% |
| 2017 | $1.84M | -61.89% |
| 2016 | $4.82M | -45.30% |
| 2015 | $8.82M | -47.86% |
| 2014 | $17M | -39.70% |
| 2013 | $28M | +36.45% |
| 2012 | $21M | N/A |
Comparison Ascendis Pharma A/S (ASND) five years revenue CAGR with competitors
Ascendis Pharma A/S (ASND) five years revenue CAGR is 175.66%.